Remimazolam: An Updated Review of a New Sedative and Anaesthetic
Sign Up to like & getrecommendations! Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s384155
Abstract: Abstract Remimazolam (CNS7056) is a novel benzodiazepine for intravenous sedation; it has an ultra-short duration of action and was recently approved for use in procedural sedation and general anaesthesia. It acts on γ-aminobutyric acid type… read more here.
Keywords: review new; updated review; remimazolam updated; new sedative ... See more keywords